Europe Neuroscience Market Size, Share & Industry Trends Analysis Report By Component (Instruments, Consumables, and Software & Services), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030
The Europe Neuroscience Market would witness market growth of 5.3% CAGR during the forecast period (2023-2030).
The governments of numerous countries are additionally making positive efforts to raise awareness about neurological illnesses and the available therapeutic choices. Additionally, the market is growing as a result of the increased use of magnetic resonance imaging (MRI), optogenetics, microscopy, and electrophysiological techniques in the diagnosis of various neurological disorders.
The top players are also creating new medical devices that offer improved effectiveness and patient compliance to increase their product portfolio and obtain a competitive advantage. Furthermore, the market is expanding as more people become aware of the advantages of cutting-edge neuroscience technologies over traditional standalone imaging devices, such as combining various imaging devices with MRI and neuro microscopes.
Other reasons, such as rising government funding for research and development (R&D) activities, breakthroughs in neuroscience and neurotechnology, an increasing senior population, and enhanced health care infrastructure, are all providing a significant boost to the growth of the market as well.
In the United Kingdom, brain aneurysms affect approximately 2-3% of the population. The prevalence of this condition is higher among women than men and is more frequently observed in the adult population. The incidence rate of subarachnoid haemorrhage caused by aneurysms in the UK is estimated to be around 7 cases per 100,000 for individuals with sporadic aneurysms. An aneurysm occurs due to a weakness in a blood vessel (artery), resulting in a bulging or out-pouching that fills with blood. After an aneurysm has been treated, neuroscience plays a crucial role in patient management and follow-up. Imaging methods are used to assess treatment success, monitor the healing process, and identify potential complications. Therefore, the rising prevalence of aneurysm and similar problems will propel the expansion of the market in the coming years.
The Germany market dominated the Europe Neuroscience Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,205.9 million by 2030. The UK market is exhibiting a CAGR of 4.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 6.1% during (2023 - 2030).
Based on Component, the market is segmented into Instruments, Consumables, and Software & Services. Based on Technology, the market is segmented into Brain Imaging, Stereotaxic Surgeries, Neuro-Microscopy, Neuro-Proteomic Analysis, Neuro-Cellular Manipulation, and Others. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals, and Research & Academic Institute. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Danaher Corporation, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Terumo Corporation, B. Braun Melsungen AG, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation and Abbott Laboratories
Scope of the Study
Market Segments covered in the Report:
By Component
- Instruments
- Consumables
- Software & Services
- Brain Imaging
- Stereotaxic Surgeries
- Neuro-Microscopy
- Neuro-Proteomic Analysis
- Neuro-Cellular Manipulation
- Others
- Diagnostic Laboratories
- Hospitals
- Research & Academic Institute
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Carl Zeiss AG
- Danaher Corporation
- Koninklijke Philips N.V.
- GE HealthCare Technologies, Inc.
- Terumo Corporation
- B. Braun Melsungen AG
- Medtronic PLC
- Stryker Corporation
- Boston Scientific Corporation
- Abbott Laboratories
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Neuroscience Market, by Component
- 1.4.2 Europe Neuroscience Market, by Technology
- 1.4.3 Europe Neuroscience Market, by End User
- 1.4.4 Europe Neuroscience Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market At a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Trials and Approvals
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Oct– 2023, Jul) Leading Players
- 4.4 Porter Five Forces Analysis
- Chapter 5. Europe Neuroscience Market by Component
- 5.1 Europe Instruments Market by Country
- 5.2 Europe Consumables Market by Country
- 5.3 Europe Software & Services Market by Country
- Chapter 6. Europe Neuroscience Market by Technology
- 6.1 Europe Brain Imaging Market by Country
- 6.2 Europe Stereotaxic Surgeries Market by Country
- 6.3 Europe Neuro-Microscopy Market by Country
- 6.4 Europe Neuro-Proteomic Analysis Market by Country
- 6.5 Europe Neuro-Cellular Manipulation Market by Country
- 6.6 Europe Others Market by Country
- Chapter 7. Europe Neuroscience Market by End User
- 7.1 Europe Diagnostic Laboratories Market by Country
- 7.2 Europe Hospitals Market by Country
- 7.3 Europe Research & Academic Institute Market by Country
- Chapter 8. Europe Neuroscience Market by Country
- 8.1 Germany Neuroscience Market
- 8.1.1 Germany Neuroscience Market by Component
- 8.1.2 Germany Neuroscience Market by Technology
- 8.1.3 Germany Neuroscience Market by End User
- 8.2 UK Neuroscience Market
- 8.2.1 UK Neuroscience Market by Component
- 8.2.2 UK Neuroscience Market by Technology
- 8.2.3 UK Neuroscience Market by End User
- 8.3 France Neuroscience Market
- 8.3.1 France Neuroscience Market by Component
- 8.3.2 France Neuroscience Market by Technology
- 8.3.3 France Neuroscience Market by End User
- 8.4 Russia Neuroscience Market
- 8.4.1 Russia Neuroscience Market by Component
- 8.4.2 Russia Neuroscience Market by Technology
- 8.4.3 Russia Neuroscience Market by End User
- 8.5 Spain Neuroscience Market
- 8.5.1 Spain Neuroscience Market by Component
- 8.5.2 Spain Neuroscience Market by Technology
- 8.5.3 Spain Neuroscience Market by End User
- 8.6 Italy Neuroscience Market
- 8.6.1 Italy Neuroscience Market by Component
- 8.6.2 Italy Neuroscience Market by Technology
- 8.6.3 Italy Neuroscience Market by End User
- 8.7 Rest of Europe Neuroscience Market
- 8.7.1 Rest of Europe Neuroscience Market by Component
- 8.7.2 Rest of Europe Neuroscience Market by Technology
- 8.7.3 Rest of Europe Neuroscience Market by End User
- Chapter 9. Company Profiles
- 9.1 Carl Zeiss AG
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Product Launches and Product Expansions:
- 9.1.6 SWOT Analysis
- 9.2 Danaher Corporation
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Acquisition and Mergers:
- 9.2.6 SWOT Analysis
- 9.3 Abbott Laboratories
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Trials and Approvals:
- 9.3.5.2 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
- 9.4 Koninklijke Philips N.V.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.5.2 Product Launches and Product Expansions:
- 9.4.5.3 Acquisition and Mergers:
- 9.4.6 SWOT Analysis
- 9.5 B. Braun Melsungen AG
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.6 SWOT Analysis
- 9.6 Medtronic PLC
- 9.6.1 Company overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.6 SWOT Analysis
- 9.7 Boston Scientific Corporation
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Trials and Approvals:
- 9.7.5.2 Acquisition and Mergers:
- 9.7.6 SWOT Analysis
- 9.8 Terumo Corporation
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Partnerships, Collaborations, and Agreements:
- 9.8.6 SWOT Analysis
- 9.9 GE HealthCare Technologies, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expenses
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.6 SWOT Analysis
- 9.10. Stryker Corporation
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 Recent strategies and developments:
- 9.10.5.1 Partnerships, Collaborations, and Agreements:
- 9.10.5.2 Product Launches and Product Expansions:
- 9.10.5.3 Trials and Approvals:
- 9.10.6 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook